Each clinical stage reflects neuropathologic changes in the brain as defined by AD neuropathological changes, which describe the presence of Aβ and tau protein deposition as well as the density of neuritic plaques, progressing in a predictable manner in the brain [153]. The gene discussed is MAPT; the disease is Alzheimer disease.